Cold Plasma-Enabled Interface Engineering and In-Situ Functionalization of Printable Feedstocks in Additive Manufacturing: Mechanisms, Materials, and Applications.

Pharmaceutics · 2026 · PMC13415086 · PMID 42514947

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Furthermore, the regulatory implications of implementing hybrid CP-AM platforms in pharmaceutical AM and bioprinting applications are highly significant and complex, as these systems merge multiple regulated sectors into a single integrated platform.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.